These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 8707286)

  • 1. Enhanced expression of the protein kinase substrate annexin in human hepatocellular carcinoma.
    Masaki T; Tokuda M; Ohnishi M; Watanabe S; Fujimura T; Miyamoto K; Itano T; Matsui H; Arima K; Shirai M; Maeba T; Sogawa K; Konishi R; Taniguchi K; Hatanaka Y; Hatase O; Nishioka M
    Hepatology; 1996 Jul; 24(1):72-81. PubMed ID: 8707286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma.
    Mohammad HS; Kurokohchi K; Yoneyama H; Tokuda M; Morishita A; Jian G; Shi L; Murota M; Tani J; Kato K; Miyoshi H; Deguchi A; Himoto T; Usuki H; Wakabayashi H; Izuishi K; Suzuki Y; Iwama H; Deguchi K; Uchida N; Sabet EA; Arafa UA; Hassan AT; El-Sayed AA; Masaki T
    Int J Oncol; 2008 Dec; 33(6):1157-63. PubMed ID: 19020748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
    Tátrai P
    Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
    Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
    Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of human macrophage metalloelastase gene in hepatocellular carcinoma: correlation with angiostatin generation and its clinical significance.
    Gorrin Rivas MJ; Arii S; Furutani M; Harada T; Mizumoto M; Nishiyama H; Fujita J; Imamura M
    Hepatology; 1998 Oct; 28(4):986-93. PubMed ID: 9755235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pp60c-src activation in hepatocellular carcinoma of humans and LEC rats.
    Masaki T; Okada M; Shiratori Y; Rengifo W; Matsumoto K; Maeda S; Kato N; Kanai F; Komatsu Y; Nishioka M; Omata M
    Hepatology; 1998 May; 27(5):1257-64. PubMed ID: 9581679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RECK gene expression in hepatocellular carcinoma: correlation with invasion-related clinicopathological factors and its clinical significance. Reverse-inducing--cysteine-rich protein with Kazal motifs.
    Furumoto K; Arii S; Mori A; Furuyama H; Gorrin Rivas MJ; Nakao T; Isobe N; Murata T; Takahashi C; Noda M; Imamura M
    Hepatology; 2001 Jan; 33(1):189-95. PubMed ID: 11124835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of NET-1 gene and protein in hepatocellular carcinoma and related tissues].
    Chen L; Shen AG; Wang GL; Lu P; Li XY
    Ai Zheng; 2006 Mar; 25(3):320-5. PubMed ID: 16536986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Id proteins in human hepatocellular carcinoma: relevance to tumor dedifferentiation.
    Damdinsuren B; Nagano H; Kondo M; Yamamoto H; Hiraoka N; Yamamoto T; Marubashi S; Miyamoto A; Umeshita K; Dono K; Nakamori S; Wakasa K; Sakon M; Monden M
    Int J Oncol; 2005 Feb; 26(2):319-27. PubMed ID: 15645115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential role of bcl-2 mRNA and protein exression in hepatocellular carcinomas.
    Ravazoula P; Tsamandas AC; Kardamakis D; Gogos C; Karatza C; Thomopoulos K; Tepetes K; Kourelis T; Petsas T; Bonikos DS; Karavias D
    Anticancer Res; 2002; 22(3):1799-805. PubMed ID: 12168872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of c-Yes expression in the nuclei of hepatocellular carcinoma cells: involvement in the early stages of hepatocarcinogenesis.
    Nonomura T; Masaki T; Morishita A; Jian G; Uchida N; Himoto T; Izuishi K; Iwama H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
    Int J Oncol; 2007 Jan; 30(1):105-11. PubMed ID: 17143518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ expression patterns of melanoma inhibitory activity 2 in healthy and diseased livers.
    Hellerbrand C; Bataille F; Schlegel J; Hartmann A; Mühlbauer M; Schölmerich J; Büttner R; Hofstädter F; Bosserhoff AK
    Liver Int; 2005 Apr; 25(2):357-66. PubMed ID: 15780062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma.
    Schuierer MM; Bataille F; Weiss TS; Hellerbrand C; Bosserhoff AK
    Oncol Rep; 2006 Sep; 16(3):451-6. PubMed ID: 16865242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of HNF-1 alpha and HNF-1 beta in various histological differentiations of hepatocellular carcinoma.
    Wang W; Hayashi Y; Ninomiya T; Ohta K; Nakabayashi H; Tamaoki T; Itoh H
    J Pathol; 1998 Mar; 184(3):272-8. PubMed ID: 9614379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of nm23 mRNA expression in human hepatocellular carcinoma.
    Lin LI; Lee PH; Wu CM; Lin JK
    Anticancer Res; 1998; 18(1B):541-6. PubMed ID: 9568175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular distribution of transcripts for tissue inhibitor of metalloproteinases 1 and 2 in human hepatocellular carcinomas.
    Nakatsukasa H; Ashida K; Higashi T; Ohguchi S; Tsuboi S; Hino N; Nouso K; Urabe Y; Kinugasa N; Yoshida K; Uematsu S; Ishizaki M; Kobayashi Y; Tsuji T
    Hepatology; 1996 Jul; 24(1):82-8. PubMed ID: 8707287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
    Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
    J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation.
    Koga H; Sakisaka S; Ohishi M; Kawaguchi T; Taniguchi E; Sasatomi K; Harada M; Kusaba T; Tanaka M; Kimura R; Nakashima Y; Nakashima O; Kojiro M; Kurohiji T; Sata M
    Hepatology; 1999 Mar; 29(3):688-96. PubMed ID: 10051469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy.
    Ohguchi S; Nakatsukasa H; Higashi T; Ashida K; Nouso K; Ishizaki M; Hino N; Kobayashi Y; Uematsu S; Tsuji T
    Hepatology; 1998 Feb; 27(2):599-607. PubMed ID: 9462663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.